Literature DB >> 21726448

Efficacy of tension-free vaginal tape compared with transobturator tape in the treatment of stress urinary incontinence in women: analysis of learning curve, perioperative changes of voiding function.

Hiroki Ito1, Hiroyuki Yamanaka, Masayuki Hagiwara, Toru Furuuchi, Kazuhiro Matsumoto, Kunimitsu Kanai, Kiichiro Kodaira, Akiharu Ninomiya, So Nakamura.   

Abstract

BACKGROUND: In this study, by comparing TVT surgery and TOT surgery for stress urinary incontinence in women, the characteristics and learning curves of both operative methods were studied.
METHODS: A total of 83 women with stress urinary incontinence treated with tension-free vaginal tape (TVT) (n = 38) or transobturator tape (TOT) (n = 45) at Saiseikai Central Hospital between April 2004 and September 2009 were included. We compare the outcomes and learning curves between TVT surgery and TOT surgery. In statistical analysis, Student's t test, Fisher's exact test, and Mann-Whitney's U test were used.
RESULTS: The surgical durations were 37.4 ± 15.7 minutes with TVT surgery and 31.0 ± 8.3 minutes with TOT surgery. A longer period of time was required for TVT surgery (p = 0.025). The residual urine at post-operative day 1 was higher in TVT surgery (25.9 ± 44.2 ml) than in TOT surgery (10.6 ± 19.2 ml) (p = 0.0452). The surgical duration of TVT surgery was shortened after the operator had performed 15 operations (p = 0.019).
CONCLUSIONS: In comparison of TVT surgery and TOT surgery, the surgical duration of TVT surgery was longer and the residual urine of TVT surgery was higher at post-operative day 1. Surgical experience could shorten the duration of TVT surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21726448      PMCID: PMC3141808          DOI: 10.1186/1471-2490-11-13

Source DB:  PubMed          Journal:  BMC Urol        ISSN: 1471-2490            Impact factor:   2.264


  15 in total

Review 1.  Tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials of effectiveness.

Authors:  Giacomo Novara; Vincenzo Ficarra; Rafael Boscolo-Berto; Silvia Secco; Stefano Cavalleri; Walter Artibani
Journal:  Eur Urol       Date:  2007-06-21       Impact factor: 20.096

2.  [TOT in the treatment of the stress urinary incontinence: our experience, comparing it with the TVT].

Authors:  J Jiménez Calvo; A Hualde Alfaro; A De Pablo Cárdenas; J L Cebrian Lostal; S Alvarez Bandres; O Raigoso Ortega
Journal:  Actas Urol Esp       Date:  2007 Nov-Dec       Impact factor: 0.994

3.  Retropubic versus transobturator midurethral slings for stress incontinence.

Authors:  Holly E Richter; Michael E Albo; Halina M Zyczynski; Kimberly Kenton; Peggy A Norton; Larry T Sirls; Stephen R Kraus; Toby C Chai; Gary E Lemack; Kimberly J Dandreo; R Edward Varner; Shawn Menefee; Chiara Ghetti; Linda Brubaker; Ingrid Nygaard; Salil Khandwala; Thomas A Rozanski; Harry Johnson; Joseph Schaffer; Anne M Stoddard; Robert L Holley; Charles W Nager; Pamela Moalli; Elizabeth Mueller; Amy M Arisco; Marlene Corton; Sharon Tennstedt; T Debuene Chang; E Ann Gormley; Heather J Litman
Journal:  N Engl J Med       Date:  2010-05-17       Impact factor: 91.245

4.  Clinical and ultrasonographic correlations following three surgical anti-incontinence procedures (TOT, TVT and TVT-O).

Authors:  Gautier Chene; Benjamin Cotte; Anne-Sylvie Tardieu; Denis Savary; Aslam Mansoor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-29

5.  [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women].

Authors:  E Delorme
Journal:  Prog Urol       Date:  2001-12       Impact factor: 0.915

6.  Tension-free vaginal tape sling for recurrent stress incontinence after transobturator tape sling failure.

Authors:  Robert D Moore; Kendra Gamble; John R Miklos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-26

Review 7.  An overview of stress urinary incontinence treatment in women.

Authors:  Athanasios G Papatsoris; Michael Chrisofos; Nikolaos Antoniou; Aristomenis Gekas; Charalambos Deliveliotis
Journal:  Aging Clin Exp Res       Date:  2007-08       Impact factor: 3.636

8.  Transvaginal vs transobturator approach for synthetic sling placement in patients with stress urinary incontinence.

Authors:  S Charalambous; S Touloupidis; G Fatles; A G Papatsoris; Ch Kalaitzis; S Giannakopoulos; V Rombis
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-08-29

9.  Tension-free vaginal tape, suprapubic arc sling, and transobturator tape in the treatment of mixed urinary incontinence in women.

Authors:  Jae-Seung Paick; Seung-June Oh; Soo Woong Kim; Ja Hyeon Ku
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-06-13

10.  Factors influencing the outcome of mid urethral sling procedures for female urinary incontinence.

Authors:  Jae-Seung Paick; Min Chul Cho; Seung-June Oh; Soo Woong Kim; Ja Hyeon Ku
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

View more
  4 in total

1.  The "learning curve" for retropubic mid-urethral sling procedures: a retrospective cohort study.

Authors:  Paul Hilton; Karen Rose
Journal:  Int Urogynecol J       Date:  2015-10-02       Impact factor: 2.894

2.  A Danish national population-based cohort study of synthetic midurethral slings, 2007-2011.

Authors:  Margrethe Foss Hansen; Gunnar Lose; Hrefna Bóel Sigurdardòttir; Kim Oren Gradel
Journal:  Int Urogynecol J       Date:  2018-08-02       Impact factor: 2.894

3.  Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention.

Authors:  Clément Lazarus; Romana Haneef; Philippe Ravaud; Isabelle Boutron
Journal:  BMC Med Res Methodol       Date:  2015-10-13       Impact factor: 4.615

4.  TVT versus TOT in the treatment of female stress urinary incontinence: a systematic review and meta-analysis.

Authors:  Zhong-Ming Huang; He Xiao; Zhi-Gang Ji; Wei-Gang Yan; Yan-Sheng Zhang
Journal:  Ther Clin Risk Manag       Date:  2018-11-20       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.